鉴别孤立性纤维性肿瘤/血管外皮细胞瘤与脑膜瘤的临床与影像特征
本研究纳入84例病例(5例SFT/HPC、72例WHO I级脑膜瘤、7例WHO II级脑膜瘤),评估临床特征及常规MRI、灌注MRI和MRS参数,通过多因素logistic回归分析寻找鉴别SFT/HPC与脑膜瘤的因素。结果显示年龄<45岁和短回波时间MRS肌醇≥6.347与SFT/HPC诊断相关,具有高灵敏度和特异度;未发现鉴别WHO I级与II级脑膜瘤的因素。
要点
- 年龄<45岁和短回波时间MRS肌醇≥6.347有助于术前鉴别SFT/HPC与脑膜瘤。
- SFT/HPC患者多为男性且较脑膜瘤患者年轻。
- 未发现鉴别WHO I级与II级脑膜瘤的因素。
核心结论
- 年龄和MRS计算的肌醇水平是术前区分SFT/HPC与脑膜瘤的有用因素。
研究设计与样本
- 回顾性分析84例病例,包括5例SFT/HPC、72例WHO I级脑膜瘤和7例WHO II级脑膜瘤。
- 评估临床特征、常规MRI、灌注MRI和MRS LCModel参数,采用多因素logistic回归分析。
主要发现
- SFT/HPC患者多为男性且较脑膜瘤患者年轻。
- 脑膜瘤T2加权图像百分比高于SFT/HPC。
- SFT/HPC与脑膜瘤在长回波时间MRS的谷氨酸、磷酸胆碱、肌醇、甘油磷酸胆碱+磷酸胆碱水平及短回波时间MRS的肌醇水平存在显著差异。
- 逐步logistic回归显示年龄<45岁和短回波时间MRS肌醇≥6.347与SFT/HPC诊断相关,具有高灵敏度和特异度。
- 未发现鉴别WHO I级与II级脑膜瘤的因素。
关键数值与推荐
- 年龄<45岁和短回波时间MRS肌醇≥6.347与SFT/HPC诊断相关。
临床怎么用
- 术前可结合年龄和MRS肌醇水平辅助鉴别SFT/HPC与脑膜瘤,以指导治疗和随访计划。
局限性
- SFT/HPC样本量小(5例),结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Solitary fibrous tumor/hemangiopericytoma (SFT/HPC) and meningioma exhibit similar radiographic features; however, they differ in their prognoses. Preoperative differentiation between them is important for determining the treatment and follow-up plan. The aim of this study was to determine the factors that can be used to differentiate SFT/HPC from meningioma and World Health Organization (WHO) grade I from grade II meningioma. METHODS: The analysis included 84 cases: 5 of SFT/HPC, 72 of WHO grade I meningioma, and 7 of WHO grade II meningioma. Clinical characteristics and conventional magnetic resonance imaging, perfusion magnetic resonance imaging, and magnetic resonance spectroscopy (MRS) LCModel parameters were evaluated via multivariate logistic regression analysis to identify the factors that distinguish SFT/HPC from meningioma. RESULTS: Patients with SFT/HPC were mostly men and were younger than those with meningioma. The percentage of T2-weighted images in meningioma was greater than that in SFT/HPC. There were significant differences between SFT/HPC and meningioma in levels of glutamate, phosphocholine, myo-inositol, or glycerophosphocholine + phosphocholine derived from long echo-time MRS, and myo-inositol derived from short echo-time MRS. Stepwise logistic regression analysis revealed that the age of <45 years and myo-inositol in short echo-time MRS of ≧6.347 were associated with a diagnosis of SFT/HPC with high sensitivity and specificity. However, no factors were found that differentiated WHO grade I meningioma from WHO grade II meningioma. CONCLUSIONS: Age and myo-inositol level calculated from MRS are useful factors for distinguishing SFT/HPC from meningioma preoperatively.
引用
- Ohba S, Murayama K, Nishiyama Y, et al. Clinical and Radiographic Features for Differentiating Solitary Fibrous Tumor/Hemangiopericytoma From Meningioma. World Neurosurg. 2019. PMID: 31233926. doi:10.1016/j.wneu.2019.06.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。